Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Cancer Diagnosis (111202)"
|Up a level|
- Subjects classification (48321)
- Australian and New Zealand Standard Research Classification (48321)
Group by: Authors/Creators | Item Type
Number of items at this level: 45.
Aitken, Joanne, Elwood, Mark, Baade, Peter D., Youl, Philippa, & English, Dallas R. (2009) Clinical whole-body skin examination reduces the incidence of thick melanomas. International Journal of Cancer, 126(2), pp. 450-458.
Antony, Joyce, Gopalan, Vinod, Smith, Robert A., & Lam, Alfred King-Yin (2012) Carcinoma ex pleomorphic adenoma : a comprehensive review of clinical, pathological and molecular data. Head and Neck Pathology, 6(1), pp. 1-9.
Baade, Peter, Dasgupta, Paramita, Aitken, Joanne, & Turrell, Gavin (2011) Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland. Medical Journal of Australia, 195(6), pp. 350-354.
Baade, Peter, Meng, Xingqiong, Youl, Philippa, Aitken, Joanne, Dunn, Jeff, & Chambers, Suzanne (2011) The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiology, Biomarkers and Prevention, 20(7), pp. 1410-1420.
Baade, Peter, Turrell, Gavin, & Aitken, Joanne (2011) Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: A cross-sectional, multilevel study. Journal of Epidemiology and Community Health: an international peer-reviewed journal for health professionals and researchers in all areas of epidemiology, 65, pp. 1037-1043.
Baade, Peter, Youlden, Danny, & Chambers, Suzanne (2011) When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Medical Journal of Australia, 194(2), pp. 73-77.
Baade, Peter D., Youl, Philippa H., Janda, Monika, Whiteman, David C., Del Mar, Christopher B., & Aitken, Joanne F. (2008) Factors associated with the number of lesions excised for each skin cancer : a study of primary care physicians in Queensland, Australia. Archives of Dermatology, 144(11), pp. 1468-1476.
Baade, Peter D., Youlden, Danny R., & Krnjacki, Lauren J. (2009) International epidemiology of prostate cancer : geographical distribution and secular trends. Molecular Nutrition & Food Research, 53(2), pp. 171-184.
Beadle, Geoffrey, Baade, Peter, & Fritschi, Lin (2009) Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers. Annals of Oncology, 20(1), pp. 103-109.
Chai, Ryan C., Lim, Yenkai, Frazer, Ian H., Wan, Yunxia, Perry, Christopher, Jones, Lee, et al. (2016) A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients. BMC Cancer, 16, Article-178.
Chambers, Suzanne K., Lynch, Brigid M., Aitken, Joanne, & Baade, Peter D. (2009) Relationship over time between psychological distress and physical activity in colorectal cancer survivors. Journal of Clinical Oncology, 27(10), pp. 1600-1606.
Chambers, Suzanner, Baade, Peter, Meng, Xingqiong, Youl, Philippa, Aitken, Joanne, & Dunn, Jeff (2011) Survivor identity after colorectal cancer: Antecedents, prevalence and outcomes. Psycho-Oncology, Online(Online), pp. 1-8.
Coory , M., Fong , K., Bowman , R., & Hall , L. (2006) Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36(6), pp. 389-392.
Fuchs, Adrian V., Tse, Brian W.C., Pearce, Amanda K., Yeh, Mei-Chun, Fletcher, Nicholas L., Huang, Steve S., et al. (2015) Evaluation of polymeric nanomedicines targeted to PSMA: Effect of ligand on targeting efficiency. Biomacromolecules, 16(10), pp. 3235-3247.
Geller, Alan, Elwood, Mark, Swetter, Susan, Brooks, Daniel, Aitken, Joanne, Youl, Philippa, et al. (2009) Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer, 115(6), pp. 1318-1327.
Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.
Kricker, Anne, Newman, Beth M., Gertig, Dorota M., Goumas, Chris, Armes, Jane, & Armstrong, Bruce K. (2008) Why do large breast cancers still present in a population offered screening? International Journal of Cancer, 123(12), pp. 2907-2914.
Kulasinghe, Arutha, Tran, Thao Huynh Phuoc, Blick, Tony, O’Byrne, Ken, Thompson, Erik W., Warkiani, Majid E., et al. (2017) Enrichment of circulating head and neck tumour cells using spiral microfluidic technology. Scientific Reports, 7, Article number-42517.
Ladwa, Rahul, Gustafson, Sonja, McCaffrey, Elizabeth, Miles, Kenneth, & O’Byrne, Kenneth (2017) A rare case of omentum invasive prostate cancer: Staging with PSMA PET/CT imaging and response to systemic therapy. Clinical Nuclear Medicine. (In Press)
Lim, Yenkai, Sun, Charles Xiaohang, Tran, Peter, & Punyadeera, Chamindie (2016) Salivary epigenetic biomarkers in head and neck squamous cell carcinomas. Biomarkers in Medicine, 10(3), pp. 301-313.
Lose, Felicity, Lawrence, Mitchell Graham, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, et al. (2012) Kallikrein 14 is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness. Biological Chemistry, 393(5), pp. 403-412.
McDowell, Michelle, Occhipinti, Stefano, Gardiner, Robert, Baade, Peter, & Steginga, Suzanne (2009) A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. European Journal of Cancer Care, 18(6), pp. 545-555.
O’Flaherty, John D., Gray, Steven, Richard, Derek, Fennell, Dean, O’Leary, John J., Blackhall, Fiona H., et al. (2012) Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer, 76(1), pp. 19-25.
Raynor, Michael, Stephenson, Sally-Anne, Pittman, Kenneth, Walsh, David, Henderson, Michael, & Dobrovic, Alexander (2009) Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR. Journal of Hematology and Oncology, 9(424), pp. 1-11.
Rhee, H., Heathcote, P., Wood, S., Greenslade, S., Russell, P., Nelson, C., et al. (2015) Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in diagnosing localised prostate cancer. In 24th Malaysian Urological Conference (MUC 2015), 19 November 2015, Malaysia.
Rhee, H., Thomas, P., Shepherd, B., Greenslade, S., Vela, I., Russell, P., et al. (2016) PSMA pet improves diagnostic accuracy of mpMRI in localised prostate cancer as confirmed by whole mount histopathology: Implications for selection and assessment for active surveillance and focal therapy. In 31st Annual Congress of the European Association of Urology (EAU16), 11–15 March 2016, Munich, Germany.
Rhee, H., Thomas, P., Shepherd, B., Gustafson, S., Vela, I., Russell, P.J., et al. (2016) Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. The Journal of Urology, 196(4), pp. 1261-1267.
Rhee, Handoo, Ng, Keng Lim, Tse, Brian Wan-Chi, Yeh, Mei-Chun, Russell, Pamela J., Nelson, Colleen, et al. (2016) [Correspondence] Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. Pathology, 48(6), pp. 613-616.
Ribu, D. L., Shield, P. W., & Cominos, D. (2011) Displaced granulosa cells in peritoneal washings : a rare diagnostic pitfall. Cytopathology, 22(3), pp. 202-204.
Ribu, D.L., Shield, P.W., & Bligh, J.F. (2012) The varied presentation of metastatic melanoma in fine needle aspiration cytology of the breast. Cytopathology, 23(4), pp. 256-262.
Russell, Pamela (2012) Use of targeted magnetic nanoparticles for Magnetic Resonance Imaging of prostate cancer. In The 19th Annual Prostate Cancer Foundation Scientific Retreat, 25 - 27 October 2012, San Diego, CA.
Salajegheh, A., Petcu, E. B., Smith, Robert A., & Lam, A K-Y (2008) Follicular variant of papillary thyroid carcinoma : a diagnostic challenge for clinicians and pathologists. Postgraduate medical journal, 84(988), pp. 78-82.
Schmidt, Henri, Kulasinghe, Arutha, Perry, Chris, Nelson, Colleen, & Punyadeera, Chamindie (2016) A liquid biopsy for head and neck cancers. Expert Review of Molecular Diagnostics.
Sitas, Freddy, Carrara, Henri, Beral, Valerie, Newton, Rob, Reeves, Gillian, Bull, Diana, et al. (1999) Antibodies against human herpesvirus 8 in black South African patients with cancer. New England Journal of Medicine, 340(24), pp. 1863-1871.
Skerman, Helen M., Yates, Patsy M., & Battistutta, Diana (2009) Multivariate methods to identify cancer-related symptom clusters. Research in Nursing & Health, 32(3), pp. 345-360.
Tse, B.W.C., Cowin, G.J., Soekmadji, C., Jovanovic, L., Vasireddy, R., Ling, M.T., et al. (2014) Enhancing MRI of prostate cancer using PSMA-targeting iron oxide magnetic nanoparticles. In 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand (USANZ 2014), 16–19 March 2014, Brisbane, Qld.
Tse, Brian W-C, Fuchs, Adrian V., Huang, Steve S., Heston, Warren DW, Yeh, Mei-Chun, Whittaker, Andrew K., et al. (2015) Multimodal hyperbranched polymers targeting prostate specific membrane antigen (PSMA) for imaging of prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Williams, Elizabeth D. & Thompson, Erik W. (2015) How cancer doctors use personalized medicine to target variations unique to each tumour. Conversation.
Winter, Sutart, Stephenson, Sally-Anne, Subramaniam, Selva, Paleri, Vinidh, Ha, Kien, Marnane, Conor, et al. (2009) Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC Cancer, 9(424), pp. 1-15.
Wu, Yi-Long, Sequist, Lecia V., Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, et al. (2016) EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: Analysis of LUX-Lung 3 and 6. British Journal of Cancer, 116, pp. 175-185.
You, Jingjing, Fitzgerald, Anna, Cozzi, Paul, Zhao, Zhenjun, Graham, Peter, Russell, Pamela, et al. (2010) Post-translation modification of proteins in tears. Electrophoresis, 31(11), pp. 1853-1861.
You, Jingjing, Willcox, Mark, Fitzgerald, Anna, Schiller, Belinda, Cozzi, Paul J., Russell, Pamela J., et al. (2015) Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling. Analytical Biochemistry, 496, pp. 30-34.
Youl, P.H., Janda, M., Aitken, J.F., Del Mar, C.B., Whiteman, D.C., & Baade, P.D. (2011) Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice. British Journal Of Dermatology, 165(1), pp. 35-43.
Youlden, Danny & Baade, Peter (2011) The relative risk of second primary cancers in Queensland, Australia: A retrospective cohort study. BMC Cancer, 11(83), pp. 1-12.
Youlden, Danny, Baade, Peter, Valery, Patricia, Ward, Leisa, Green, Adele, & Aitken, Joanne (2011) Differentials in survival for childhood cancer in Australia by remoteness of residence and area disadvantage. Cancer Epidemiology, Biomarkers and Prevention, 20(8), pp. 1649-1656.